Acasti Pharma, Inc. (ACST) Financials
ACST Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 57.4 million | 8.7 million |
2023-09-30 | 57.5 million | 8.4 million |
2023-06-30 | 55.2 million | 6.8 million |
2023-03-31 | 58.5 million | 8.3 million |
ACST Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -1.4 million | 245787 |
2023-09-30 | -1.6 million | 206026 |
2023-06-30 | -4.7 million | 58921 |
2023-03-31 | -2.5 million | 238005 |
ACST Net Income
No data available :(
ACST Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 18.9 million | - | 18094 |
2023-09-30 | 19.9 million | - | 33847 |
2023-06-30 | 16.4 million | - | 60431 |
2023-03-31 | 20.6 million | - | 358485 |
ACST Shares Outstanding
ACST Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 1.1 million | 1.2 million | 22618 |
2023-09-30 | - | 338471 | 1.2 million | 31639 |
2023-06-30 | - | 827162 | 1.4 million | 45323 |
2023-03-31 | 5913 | 1.2 million | 1.8 million | 37696 |
ACST Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 2.3 million |
2023-09-30 | - | 1.5 million |
2023-06-30 | - | 3.4 million |
2023-03-31 | -23652 | 10.4 million |
ACST
Price: $2.96
52 week price:
Payout Ratio Range:
Earnings Per Share: -5.68 USD
P/E Ratio: -0.41
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 172300
Ebitda: -8.8 millionMarket Capitalization: 32.0 million